DJIA 16,351.38 293.03 1.82%
NASDAQ 4,749.98 113.87 2.46%
S&P 500 1,948.86 35.01 1.83%
market minute promo

Eli Lilly & Co. (NYSE: LLY)

81.81 2.01 (2.52%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

LLY $81.81 2.52%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $80.71
Previous Close $79.80
Daily Range $80.30 - $81.83
52-Week Range $60.58 - $90.18
Market Cap $90.7B
P/E Ratio 41.35
Dividend (Yield) $2.00 (2.5%)
Ex-Dividend Date
Dividend Pay Date
Volume 3,254,109
Average Daily Volume 4,690,524
Current FY EPS $3.27




Drug Makers

Eli Lilly & Co. (LLY) Description

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases. Website:

News & Commentary

Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?

Are DPP-4 inhibitors like Januvia on their way out? A new long-term study from partners Eli Lilly and Boehringer Ingelheim suggests it's a possibility.

Amgen, Novartis Team Up; Bone Drug Positive in Phase III

Eli Lilly Is A Boring Stock... I Like Boring!

VHT, MRK, BMY, LLY: Large Outflows Detected at ETF

ESC- Case Builds For Jardiance

Bristol-Myers Inks Another Immuno-Oncology Drug Deal

Why Eli Lilly (LLY) Could Beat Earnings Estimates Again

Approval Of Repatha May Give Amgen A $5B Boost.

Eli Lilly's (LLY) Diabetes Drug Synjardy Gets U.S. Approval

Buy Eli Lilly, or Will Drug-Pricing Debate Dent the Stock?

See More LLY News...

LLY's Top Competitors

LLY $81.81 (2.52%)
Current stock: LLY
JNJ $93.35 (1.37%)
Current stock: JNJ
NVS $95.60 (0.97%)
Current stock: NVS
RHHBY $33.32 (-0.15%)
Current stock: RHHBY